BIOMARKERS FOR PREDICTING THE SENSITIVITY AND RESPONSE OF PROTEIN KINASE CK2-MEDIATED DISEASES TO CK2 INHIBITORS
Disclosed are biomarkers for determining the sensitivity of protein kinase CK2-mediated diseases, such as proliferative and/or inflammatory disorders, to treatment with CK2 inhibitors. These biomarkers can be used to predict or select subjects likely to be responsive to treatment with a CK2 inhibito...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BLIESATH, JOSHUA R HO, CAROLINE B VONHOFF, DANIEL D SIDDIQUI-JAIN, ADAM ANDERES, KENNA PADGETT, CLAIRE S DRYGIN, DENIS O'BRIEN, SEAN RICE, WILLIAM G LIM, JOHN, K. C |
description | Disclosed are biomarkers for determining the sensitivity of protein kinase CK2-mediated diseases, such as proliferative and/or inflammatory disorders, to treatment with CK2 inhibitors. These biomarkers can be used to predict or select subjects likely to be responsive to treatment with a CK2 inhibitor, and to treat or monitor subjects undergoing treatment with a CK2 inhibitor. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2776278A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2776278A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2776278A13</originalsourceid><addsrcrecordid>eNqNi0EKwjAQRbtxIeod5gJdWMG6TZOJHUozJTMIrkqRuBIt1PtjBA_g6sP7762LuSHuTewwCniOMER0ZJXCGbRFEAxCShfSK5jgIKIMHASBfVZZkQJ0FEwmtqvKPsdG0YEjwQwFlL8HUGipIeUo22J1nx5L2v12U4BHtW2Z5teYlnm6pWd6j9ZUdX2s6pPZH_5QPmYxN0I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BIOMARKERS FOR PREDICTING THE SENSITIVITY AND RESPONSE OF PROTEIN KINASE CK2-MEDIATED DISEASES TO CK2 INHIBITORS</title><source>esp@cenet</source><creator>BLIESATH, JOSHUA R ; HO, CAROLINE B ; VONHOFF, DANIEL D ; SIDDIQUI-JAIN, ADAM ; ANDERES, KENNA ; PADGETT, CLAIRE S ; DRYGIN, DENIS ; O'BRIEN, SEAN ; RICE, WILLIAM G ; LIM, JOHN, K. C</creator><creatorcontrib>BLIESATH, JOSHUA R ; HO, CAROLINE B ; VONHOFF, DANIEL D ; SIDDIQUI-JAIN, ADAM ; ANDERES, KENNA ; PADGETT, CLAIRE S ; DRYGIN, DENIS ; O'BRIEN, SEAN ; RICE, WILLIAM G ; LIM, JOHN, K. C</creatorcontrib><description>Disclosed are biomarkers for determining the sensitivity of protein kinase CK2-mediated diseases, such as proliferative and/or inflammatory disorders, to treatment with CK2 inhibitors. These biomarkers can be used to predict or select subjects likely to be responsive to treatment with a CK2 inhibitor, and to treat or monitor subjects undergoing treatment with a CK2 inhibitor.</description><language>eng ; fre</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110407&DB=EPODOC&CC=CA&NR=2776278A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25566,76549</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110407&DB=EPODOC&CC=CA&NR=2776278A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BLIESATH, JOSHUA R</creatorcontrib><creatorcontrib>HO, CAROLINE B</creatorcontrib><creatorcontrib>VONHOFF, DANIEL D</creatorcontrib><creatorcontrib>SIDDIQUI-JAIN, ADAM</creatorcontrib><creatorcontrib>ANDERES, KENNA</creatorcontrib><creatorcontrib>PADGETT, CLAIRE S</creatorcontrib><creatorcontrib>DRYGIN, DENIS</creatorcontrib><creatorcontrib>O'BRIEN, SEAN</creatorcontrib><creatorcontrib>RICE, WILLIAM G</creatorcontrib><creatorcontrib>LIM, JOHN, K. C</creatorcontrib><title>BIOMARKERS FOR PREDICTING THE SENSITIVITY AND RESPONSE OF PROTEIN KINASE CK2-MEDIATED DISEASES TO CK2 INHIBITORS</title><description>Disclosed are biomarkers for determining the sensitivity of protein kinase CK2-mediated diseases, such as proliferative and/or inflammatory disorders, to treatment with CK2 inhibitors. These biomarkers can be used to predict or select subjects likely to be responsive to treatment with a CK2 inhibitor, and to treat or monitor subjects undergoing treatment with a CK2 inhibitor.</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi0EKwjAQRbtxIeod5gJdWMG6TZOJHUozJTMIrkqRuBIt1PtjBA_g6sP7762LuSHuTewwCniOMER0ZJXCGbRFEAxCShfSK5jgIKIMHASBfVZZkQJ0FEwmtqvKPsdG0YEjwQwFlL8HUGipIeUo22J1nx5L2v12U4BHtW2Z5teYlnm6pWd6j9ZUdX2s6pPZH_5QPmYxN0I</recordid><startdate>20110407</startdate><enddate>20110407</enddate><creator>BLIESATH, JOSHUA R</creator><creator>HO, CAROLINE B</creator><creator>VONHOFF, DANIEL D</creator><creator>SIDDIQUI-JAIN, ADAM</creator><creator>ANDERES, KENNA</creator><creator>PADGETT, CLAIRE S</creator><creator>DRYGIN, DENIS</creator><creator>O'BRIEN, SEAN</creator><creator>RICE, WILLIAM G</creator><creator>LIM, JOHN, K. C</creator><scope>EVB</scope></search><sort><creationdate>20110407</creationdate><title>BIOMARKERS FOR PREDICTING THE SENSITIVITY AND RESPONSE OF PROTEIN KINASE CK2-MEDIATED DISEASES TO CK2 INHIBITORS</title><author>BLIESATH, JOSHUA R ; HO, CAROLINE B ; VONHOFF, DANIEL D ; SIDDIQUI-JAIN, ADAM ; ANDERES, KENNA ; PADGETT, CLAIRE S ; DRYGIN, DENIS ; O'BRIEN, SEAN ; RICE, WILLIAM G ; LIM, JOHN, K. C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2776278A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2011</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>BLIESATH, JOSHUA R</creatorcontrib><creatorcontrib>HO, CAROLINE B</creatorcontrib><creatorcontrib>VONHOFF, DANIEL D</creatorcontrib><creatorcontrib>SIDDIQUI-JAIN, ADAM</creatorcontrib><creatorcontrib>ANDERES, KENNA</creatorcontrib><creatorcontrib>PADGETT, CLAIRE S</creatorcontrib><creatorcontrib>DRYGIN, DENIS</creatorcontrib><creatorcontrib>O'BRIEN, SEAN</creatorcontrib><creatorcontrib>RICE, WILLIAM G</creatorcontrib><creatorcontrib>LIM, JOHN, K. C</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BLIESATH, JOSHUA R</au><au>HO, CAROLINE B</au><au>VONHOFF, DANIEL D</au><au>SIDDIQUI-JAIN, ADAM</au><au>ANDERES, KENNA</au><au>PADGETT, CLAIRE S</au><au>DRYGIN, DENIS</au><au>O'BRIEN, SEAN</au><au>RICE, WILLIAM G</au><au>LIM, JOHN, K. C</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BIOMARKERS FOR PREDICTING THE SENSITIVITY AND RESPONSE OF PROTEIN KINASE CK2-MEDIATED DISEASES TO CK2 INHIBITORS</title><date>2011-04-07</date><risdate>2011</risdate><abstract>Disclosed are biomarkers for determining the sensitivity of protein kinase CK2-mediated diseases, such as proliferative and/or inflammatory disorders, to treatment with CK2 inhibitors. These biomarkers can be used to predict or select subjects likely to be responsive to treatment with a CK2 inhibitor, and to treat or monitor subjects undergoing treatment with a CK2 inhibitor.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_CA2776278A1 |
source | esp@cenet |
subjects | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING |
title | BIOMARKERS FOR PREDICTING THE SENSITIVITY AND RESPONSE OF PROTEIN KINASE CK2-MEDIATED DISEASES TO CK2 INHIBITORS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T15%3A21%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BLIESATH,%20JOSHUA%20R&rft.date=2011-04-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2776278A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |